Skip to main content

Table 2 Univariate analysis of overall survival time in 59 patients with bladder urothelial carcinoma

From: SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy

Variable

All cases

Overall survival (months)

χ2

P valuea

Mean

Media

Age (years)

   

0.12

0.73

  ≤ 60

14

36.7

23.0

  

  > 60

45

45.7

43.0

  

Gender

   

0.01

0.98

 Male

50

45.0

39.0

  

 Female

9

33.9

17.0

  

Tumor size (cm)

   

0.47

0.50

  ≤ 5

37

37.4

25.0

  

  > 5

22

49.9

63.0

  

Differentiation

   

2.80

0.09

 I-II

20

48.9

40.0

  

 III-IV

39

38.6

24.0

  

T stage

   

8.11

0.01

 T1-T2

33

51.1

39.0

  

 T3-T4

26

31.5

17.0

  

N stage

   

1.82

0.18

 N0

37

47.2

43.0

  

 N1-N2

22

24.3

25.0

  

AJCC stage

   

6.50

0.01

 I-II

34

48.9

38.0

  

 III-IV

25

31.9

20.0

  

SIRT4 levels

   

8.58

0.01

 High

38

47.5

37.0

  

 Low

21

27.9

24.0

  
  1. Bold values are statistically significant (P < 0.05)
  2. alog-rank test